Ethambutol

This classification denotes an antitubercular agent with the molecular formula C10H24N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8G167061QZ, chemically known as 2,2-(1,2-ethylenediimino)-di-1-butanol but generally known as ethambutol, which bears US NIH Compound Identifier 3279. European Medicines Agency schedules Ethambutol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07271MIG. The term ETHAMBUTOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules ethambutol in its Anatomical Therapeutic Chemical (ATC) Classification. ETHAMBUTOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ethambutol under HS 29221980 and SITC 51461. As of Q4 2014, ETHAMBUTOL remains the US FDA Preferred Term for this commodity. Ethambutol bears US NLM identifiers UMLS ID C0014964 and NCI Concept Code C61755. SMILES: CCC(CO)NCCNC(CC)CO.